Overview
The BMC Clinical Research Unit (CRU) is an extension of the hospital’s mission to advance science for all by creating a leading-edge space to conduct complex, diverse, and equitable clinical research on today’s most pressing health issues. With 3,000 square feet of state-of-the-art space, the BMC CRU, located in the Yawkey building, is an investment in research at the forefront of innovation and health equity.
Unit Capabilities
- Highly trained inpatient nurses for adult and pediatric participants
- Research Clinical Coordinators to support visits
- Potential for the conduct of 24-hour studies, such as pharmacokinetic studies
- Access to emergency response teams facilitating the conduct of higher risk studies
- Clinic exam rooms
- Medication and nutrition stations
- Phlebotomy and lab processing
In addition to CRU capabilities, the Clinical Research Network is also available to provide BMC’s researchers, sponsors, and the broader BMC community with high-quality staffing services, including community-engaged recruitment, to rapidly activate and manage complex and clinically important studies.
Together, the new CRU at BMC and the existing Boston University Clinical & Translational Science Institute General Clinical Research Unit will give participants, researchers and our sponsors continued access to an expansive array of services that adhere to the highest standard of safety and clinical efficiency.
For questions about the CRU at BMC, please email Anh Tran, Clinical Director, at Anh.Tran@bmc.org.
Initiating a Trial
If you are a BMC or BU researcher interested in initiating a trial, please fill out the intake form in WebCAMP. Reviewers will decide if the CRU at BMC or GCRU at BU is more appropriate based on your responses.
FAQs for BMC & BU Researchers and Study Teams
The CRU at BMC is located on the 6th floor of the Yawkey Building. The GCRU at BU CTSI is housed on the 8th floor of the Evans Building.
The CRU at BMC and GCRU at BU CTSI teams are working together to transition all higher-risk studies to the new unit. If your study is impacted, you will be notified prior to the study moving to the CRU at BMC. In addition, you will be provided with any information needed for the transition and given the opportunity to ask questions and ensure this is a streamlined process with minimal impact to the research participant. The new CRU at BMC’s expanded hours of operations will allow for more options for scheduling study participants that include the capability for overnight observation with advanced planning. Impacted studies will be provided with more information regarding options for scheduling.
For contracts negotiated before Jan. 1, 2025, studies will continue to be charged the current GCRU at BU rates for the course of their study. Starting Jan. 1, 2025, any studies using CRU at BMC space or services being negotiated will be subject to the new rates for services associated with the CRU at BMC.
If you are working on a new clinical study, please fill out the Intake Form which will be assessed by clinical staff from both the CRU at BMC and the GCRU at BU CTSI teams, and a determination about site will be made based on the level of risk of the protocol. Once a determination is made, you and your study team will be notified and provided with additional information. Click here to submit the intake form.
For inquiries about the CRU at BMC, please contact Anh Tran, Clinical Director, at Anh.Tran@bmc.org
For questions related to the GCRU at the BU CTSI, please reach out to Ridiane Denis, Director of Clinical Research Operations, at ridianed@bu.edu
Location
